Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Mitsui Chemicals Crop & Life Solutions Inc. is navigating 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. The workload is distributed across 4 distinct examiners, suggesting a broad range of technical scrutiny for their current applications. These matters are situated within 2 distinct art units, which indicates that while the examiners are varied, the subject matter remains concentrated in specific regulatory groups.
NOTTINGHAM, KYLE GREGORY is the busiest examiner for the portfolio, currently managing 1 pending action. No individual examiner holds more than 1 of the company's active cases, as the 4 pending actions are spread among the examiners. For the legal team, this necessitates managing 4 separate examiner relationships simultaneously to advance the portfolio. The concentration in 2 art units may provide some procedural consistency despite the variety of individual examiners. This allows the company to develop an understanding of the specific art units' tendencies.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 2 (50%) |
| §112 only | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NOTTINGHAM, KYLE GREGORY | 1 | 61.7% | +31.9% |
| YU, HONG | 1 | 30.9% | +5.6% |
| PRAGANI, RAJAN | 1 | 53.3% | +70.0% |
| OLSEN, KAELEIGH ELIZABETH | 1 | 50.0% | +61.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18704200 | METHODS AND COMPOSITION FOR CONTROLLING PESTS | PRAGANI, RAJAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18558823 | COMPOSITION WITH ENHANCED PLANT DISEASE CONTROL EFFECT AND RAINFASTNESS OF D-TAGATOSE | OLSEN, KAELEIGH ELIZABETH | 49d overdue |
| 18835946 | PYRAZOLE COMPOUND AND PEST CONTROL AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT | NOTTINGHAM, KYLE GREGORY | — |
| 18704200 | METHODS AND COMPOSITION FOR CONTROLLING PESTS | PRAGANI, RAJAN | — |
| Art Unit | Apps |
|---|---|
| 1614 | 2 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18835946 | PYRAZOLE COMPOUND AND PEST CONTROL AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT | NOTTINGHAM, KYLE GREGORY | — | §112 | Non-Final OA | — | Pending | Aug 05, 2024 |
| 18717122 | AGRICULTURAL CHEMICAL COMPOSITION AND METHOD FOR PRODUCING SAME | YU, HONG | 1614 | §103Other | Non-Final OA | — | Pending | Jun 06, 2024 |
| 18704200 | METHODS AND COMPOSITION FOR CONTROLLING PESTS | PRAGANI, RAJAN | 1614 | §101§103§112DPOther | Non-Final OA | — | Pending | Apr 24, 2024 |
| 18558823 | COMPOSITION WITH ENHANCED PLANT DISEASE CONTROL EFFECT AND RAINFASTNESS OF D-TAGATOSE | OLSEN, KAELEIGH ELIZABETH | 1619 | §103 | Final Rejection | 49d overdue | Pending | Nov 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial